superoxide dismutase-transduced adipose-derived mesenhymal stem cells (George Washington University)

N/A

Report date: 2025/03/20 15:15:43

Base Information

Drug Namesuperoxide dismutase-transduced adipose-derived mesenhymal stem cells (George Washington University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionSuperoxide dismutase [Mn], mitochondrial stimulants
TargetsSuperoxide dismutase [Mn], mitochondrial
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe George Washington University
China Registration ClassN/A

Develop Information

Active CompaniesThe George Washington University
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A